NeuroVive Pharmaceutical AB Publishes 2018 Annual Report

LUND, Sweden, 25 March 2019 /PRNewswire/ — NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the English version of the Annual report for 2018 is now available on the company’s website This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 10:00 a.m. CET on 25 March 2019. About NeuroVive  NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase I (KL1333) for genetic mitochondrial diseases and ...

Gepostet in der Kategorie Wirtschaft (Anzahl der ansichten:) 5

Ähnlich Nachrichten